Tg Therapeutics (TGTX) Other Non Operating Income (2011 - 2026)

Tg Therapeutics' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income changed N/A year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was -$9.3 million, a 340.13% decrease from a year earlier, with the FY2025 full-year figure at -$8.1 million, down 275.07% from the prior year.
• Other Non Operating Income rose to $2.4 million in Q1 2026 per TGTX's latest filing, from -$17.8 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $3.3 million in Q3 2025 and bottomed at -$17.8 million in Q4 2025.
• The 5-year median for Other Non Operating Income is $1.3 million (2024), against an average of -$890000.0.
• Across the five-year window, Other Non Operating Income surged 260.53% in 2023 and sank 3520.98% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $1.9 million in 2022, then sank by 865.28% to -$14.8 million in 2023, then jumped by 96.68% to -$491000.0 in 2024, then sank by 3520.98% to -$17.8 million in 2025, then jumped by 113.43% to $2.4 million in 2026.
• Per Business Quant, the three latest TGTX Other Non Operating Income figures stand at $2.4 million (Q1 2026), -$17.8 million (Q4 2025), and $3.3 million (Q3 2025).